Risk of Pneumonitis Associated With Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Network Meta-Analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have dramatically altered the treatment landscape for patients with melanoma. However, their use also generates unique immune-related adverse effects (irAEs). We performed a systematic review and network meta‐analysis to compare the risk of pneumonitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, You-Meng, Li, Wei, Chen, Zhi-Yu, Wang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568299/
https://www.ncbi.nlm.nih.gov/pubmed/34745932
http://dx.doi.org/10.3389/fonc.2021.651553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568299/
https://www.ncbi.nlm.nih.gov/pubmed/34745932
http://dx.doi.org/10.3389/fonc.2021.651553

Ejemplares similares